Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aeglea BioTherapeutics, Inc. - Common Stock (NQ:AGLE)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aeglea BioTherapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Aeglea BioTherapeutics Inc. (NASDAQ: AGLE) Leading the Way in Friday Trading Based on Percentage Gain
Via Investor Brand Network
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with a breakdown of the biggest pre-market stock movers worth reading about on Monday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Recap: Aeglea BioTherapeutics Q1 Earnings
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023
Via Benzinga
10 Short Squeeze Stocks To Watch: Aeglea Biotherapeutics, Toro Corp, AirSculpt, A Company Moves Up 4,166 Positions & More
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among... 
Via Benzinga
Why Tivic Health Systems Are Trading Lower By 23%; Here Are 20 Stocks Moving Premarket
Gainers Nanobiotix S.A. (NASDAQ: NBTX) shares surged 59.3% to $8.02 in pre-market trading after the company entered into a license agreement with Janssen Pharmaceutical for global co-development and... 
Via Benzinga
Why Gorilla Technology Group Are Trading Higher By 52%; Here Are 20 Stocks Moving Premarket
Gainers Gorilla Technology Group Inc. (NASDAQ: GRRR) shares surged 51.7% to $3.17 in pre-market trading after the company signed a $270 million contract with the Government of Egypt to implement a... 
Via Benzinga
Why Virgin Galactic Are Trading Lower By Around 18%; Here Are 20 Stocks Moving Premarket
Gainers Castellum, Inc. (NYSE: CTM) shares surged 176.6% to $1.25 in pre-market trading after dropping around 6% on Thursday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time for a final dive into the biggest pre-market stock movers this week as we check out what's happening on Friday! 
Via InvestorPlace
Crude Oil Down Over 4%; Innovative Eyewear Shares Plummet
U.S. stocks traded mostly higher toward the end of trading, with the NASDAQ Composite gaining around 100 points on Thursday. The Dow traded down 0.03% to 33,942.78 while the NASDAQ rose 0.75% to... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private... 
Via Benzinga
Nasdaq Rises 70 Points; Aeglea BioTherapeutics Shares Spike Higher
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 70 points on Thursday. The Dow traded down 0.11% to 33,912.98 while the NASDAQ rose 0.54% to 13,574.90. The S&P... 
Via Benzinga
Why Is Aeglea BioTherapeutics (AGLE) Stock Up 392% Today?
Aeglea BioTherapeutics (AGLE) stock is undergoing a massive rally on Thursday after it announced its acquisition of Spyre Therapeutics. 
Via InvestorPlace
Increased Funding for Pancreatic Cancer Trials & Treatments Rising along with Demand for New Drugs
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:POAI),(NASDAQ:AGLE),(NASDAQ:TALS),(NASDAQ:MRTX) EQNX::TICKER_END 
Via FinancialNewsMedia
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Aeglea BioTherapeutics Stock Surges Over 400% Today - What's Going On
Aeglea BioTherapeutics Inc (NASDAQ: AGLE) has acquired Spyre Therapeutics, a privately-held biotechnology company focused on developing antibody therapeutics  
Via Benzinga
Why Root Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 100.8% to $2.65 in pre-market trading after dropping 43% on Wednesday. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  Monday's session saw 41 companies set new 52-week lows. 
Via Benzinga
Why Sidus Space Shares Are Trading Lower By Around 24%; Here Are 20 Stocks Moving Premarket
Gainers Wang & Lee Group, Inc. (NASDAQ: WLGS) jumped 266.1% to $11.35 in pre-market trading after dropping 38% on Thursday. WANG & LEE GROUP priced its initial public offering of 1,600,000 shares at a... 
Via Benzinga
Crude Oil Rises Over 2%; Cutera Shares Plummet
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 80 points on Wednesday. The Dow traded down 0.12% to 33,643.89 while the NASDAQ fell 0.67% to 11,951.16.... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Nasdaq Edges Higher; US Crude Oil Inventories Increase Last Week
U.S. stocks traded higher midway through trading, with the Nasdaq Composite trading higher on Wednesday. The Dow traded up 0.35% to 33,802.08 while the NASDAQ rose 0.10% to 12,043.72. The S&P 500, also... 
Via Benzinga
Why Panbela Therapeutics Shares Are Trading Higher By Around 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers TESSCO Technologies Incorporated (NASDAQ: TESS) shares jumped 86.8% to $8.78 as it agreed to be acquired by entities affiliated with Lee Equity Partners and Twin Point Capital for $9.00 in... 
Via Benzinga
Why Are Aeglea BioTherapeutics Shares Sinking Today?
Aeglea BioTherapeutics Inc (NASDAQ: AGLE) shares are plunging in reaction to the interim results from the Phase 1/2 trial of pegtarviliase for Classical Homocystinuria and strategic alternatives... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2023
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.